Clinical High Rish for Psychosis
Showing 1 - 25 of >10,000
Ultra-high Risk for Psychosis, Clinical High Risk for Psychosis, At-risk Mental State Trial (Metacognitive Training)
Not yet recruiting
- Ultra-high Risk for Psychosis
- +2 more
- Metacognitive Training
- (no location specified)
Apr 23, 2023
Clinical High Risk for Psychosis, Ultra High Risk for Psychosis, Attenuated Psychotic Symptoms Trial in Udine (Ultra-micronized
Recruiting
- Clinical High Risk for Psychosis
- +2 more
- Ultra-micronized Palmitoylethanolamide (PEA)
-
Udine, UD, Italy
- +1 more
Sep 18, 2023
Psychosis, Psychosocial Functioning Trial (Optimal Health Program)
Not yet recruiting
- Psychosis
- Psychosocial Functioning
- Optimal Health Program
- (no location specified)
Mar 3, 2023
Clinical High Risk for Psychosis Trial in Shanghai (Virtual hand illusion (VHI))
Completed
- Clinical High Risk for Psychosis
- Virtual hand illusion (VHI)
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jan 19, 2023
Psychosis Nos/Other Trial in East Providence (Brief family engagement intervention for CHR, Treatment as usual (TAU))
Recruiting
- Psychosis Nos/Other
- Brief family engagement intervention for CHR
- Treatment as usual (TAU)
-
East Providence, Rhode IslandBradley Hospital
Oct 5, 2022
Clinical High Risk for Psychosis Trial in Chicago (Targeted Cognitive Training, Computer Games)
Completed
- Clinical High Risk for Psychosis
- Targeted Cognitive Training
- Computer Games
-
Chicago, IllinoisRush University Medical Center
Dec 1, 2022
Clinical High Risk for Psychosis (CHR) Trial in New York (CBT Skills Group for CHR Youth, Individual CBT sessions, CBT Skills
Recruiting
- Clinical High Risk for Psychosis (CHR)
- CBT Skills Group for CHR Youth
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 21, 2023
Psychosis, Suicide, Health Care Utilization Trial (Youth-Nominated Support Teams for CHR)
Not yet recruiting
- Psychosis
- +3 more
- Youth-Nominated Support Teams for CHR
- (no location specified)
Sep 23, 2022
Clinical High-Risk, Psychological Trial in Pittsburgh (Skills Group)
Recruiting
- Clinical High-Risk
- Psychological
- Skills Group
-
Pittsburgh, PennsylvaniaBellefield Towers
Jun 28, 2022
Psychotic Disorders, Prodromal Symptoms, Prodromal Schizophrenia Trial in Canada, United States (Family Focused Therapy for
Recruiting
- Psychotic Disorders
- +4 more
- Family Focused Therapy for Clinical High Risk Youth (FFT-CHR)
- Enhanced Care (EC)
-
Los Angeles, California
- +6 more
Oct 7, 2022
Clinical High Risk for Psychosis Trial in Boston (InVEST)
Recruiting
- Clinical High Risk for Psychosis
- InVEST
-
Boston, MassachusettsBeth Israel Deaconess Medical Center/ Massachusetts Mental Healt
Jun 10, 2022
Clinical High Risk for Psychosis Trial in New York (Gabapentin, Placebo)
Terminated
- Clinical High Risk for Psychosis
- Gabapentin
- Placebo
-
New York, New YorkNew York State Psychiatric Institute
Apr 30, 2022
Clinical High Risk for Developing Psychosis Trial in Calgary (Supportive therapy and CBT)
Recruiting
- Clinical High Risk for Developing Psychosis
- Supportive therapy and CBT
-
Calgary, Alberta, CanadaMathison Centre for Research and Education, University of Calgar
May 17, 2022
First Episode Psychosis (FEP), Clinical High Risk for Psychosis (CHR) Trial in New York (Screening Method (SM), Screening and
Not yet recruiting
- First Episode Psychosis (FEP)
- Clinical High Risk for Psychosis (CHR)
- Screening Method (SM)
- Screening and Communication Method (SCM)
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 19, 2022
Clinical High Risk Syndrome of Psychosis Trial in China (Sulforaphane, Placebo)
Recruiting
- Clinical High Risk Syndrome of Psychosis
- Sulforaphane
- Placebo
-
Guangzhou, Guangdong, China
- +7 more
Nov 9, 2022
Clinical High Risk for Psychosis Trial in Shanghai (active-dTMS, sham-dTMS)
Not yet recruiting
- Clinical High Risk for Psychosis
- active-dTMS
- sham-dTMS
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 14, 2021
Clinical High Risk for Psychosis Trial in New York (Pomaglumetad methionil)
Completed
- Clinical High Risk for Psychosis
- Pomaglumetad methionil
-
New York, New YorkNew York State Psychiatric Institute
Nov 5, 2021
AMP SCZ® Observational Study: PREDICT-DPACC
Recruiting
- Clinical High Risk
- +3 more
-
Irvine, California
- +41 more
Jun 6, 2023
Psychosis, Prodromal Schizophrenia, Prodromal Symptoms Trial in Glen Oaks (SCORES (Specific COgnitive Remediation with Support))
Recruiting
- Psychosis
- +2 more
- SCORES (Specific COgnitive Remediation with Support)
-
Glen Oaks, New YorkNorthwell Health- The Zucker Hillside Hospital
Nov 24, 2021
Clinical High Risk for Psychosis Trial in New Haven (Aspirin, Placebo)
Terminated
- Clinical High Risk for Psychosis
- Aspirin
- Placebo
-
New Haven, ConnecticutPRIME Research Clinic
May 13, 2021
Prodromal Schizophrenia Trial (N-Acetylcysteine, Placebo)
Not yet recruiting
- Prodromal Schizophrenia
- N-Acetylcysteine
- Placebo
- (no location specified)
Jan 5, 2022
First-episode Psychosis Trial (High Intensity Interval Training)
Not yet recruiting
- First-episode Psychosis
- High Intensity Interval Training
- (no location specified)
Mar 7, 2021
E-Detection Tool for Emerging Mental Disorders
Not yet recruiting
- Psychosis
- (no location specified)
Apr 6, 2022
Clinical High Risk Syndrome of Psychosis Trial in Guangzhou, Suzhou, Shanghai (repetitive transcranial magnetic stimulation
Recruiting
- Clinical High Risk Syndrome of Psychosis
- repetitive transcranial magnetic stimulation (rTMS)
-
Guangzhou, Guangdong, China
- +2 more
Apr 18, 2021
Ultra High Risk for Psychosis Trial in Worldwide (Omega-3 fatty acids, Placebo)
Active, not recruiting
- Ultra High Risk for Psychosis
- Omega-3 fatty acids
- Placebo
-
Vienna, Austria
- +13 more
Feb 8, 2021